Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 1
2019 2
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.
Blinova E, Samishina E, Deryabina O, Blinov D, Roshchin D, Shich E, Tumutolova O, Fedoseykin I, Epishkina A, Barakat H, Kaprin A, Zhandarov K, Perepechin D, Merinov D, Brykin G, Arutiunian K, Serebrianyi S, Mirontsev A, Kozdoba A. Blinova E, et al. Among authors: roshchin d. Int J Mol Sci. 2021 Sep 12;22(18):9856. doi: 10.3390/ijms22189856. Int J Mol Sci. 2021. PMID: 34576020 Free PMC article.
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma.
Blinova E, Buzdin A, Enikeev D, Roshchin D, Suntsova M, Samyshina E, Drobyshev A, Deryabina O, Demura T, Blinov D, Shich E, Barakat H, Borger P, Merinov D, Kachmazov A, Serebrianyi S, Tumutolova O, Potoldykova N, Zhdanov P, Grigoryan V, Perepechin D. Blinova E, et al. Among authors: roshchin d. Life (Basel). 2020 Nov 23;10(11):305. doi: 10.3390/life10110305. Life (Basel). 2020. PMID: 33238591 Free PMC article.
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.
Blinova E, Enikeev D, Roshchin D, Samyshina E, Deryabina O, Tertychnyy A, Blinov D, Kogan E, Dudina M, Barakat H, Merinov D, Kachmazov A, Serebrianyi S, Potoldykova N, Perepechin D. Blinova E, et al. Among authors: roshchin d. Cancers (Basel). 2020 May 21;12(5):1316. doi: 10.3390/cancers12051316. Cancers (Basel). 2020. PMID: 32455829 Free PMC article.